Attached files

file filename
10-K - FORM 10-K - SCOLR Pharma, Inc.d10k.htm
EX-32.2 - SECTION 906 CERTIFICATION - SCOLR Pharma, Inc.dex322.htm
EX-32.1 - SECTION 906 CERTIFICATION - SCOLR Pharma, Inc.dex321.htm
EX-31.1 - SECTION 302 CERTIFICATION - SCOLR Pharma, Inc.dex311.htm
EX-31.2 - SECTION 302 CERTIFICATION - SCOLR Pharma, Inc.dex312.htm
EX-10.44 - FORM OF COMMON STOCK PURCHASE WARRANT - SCOLR Pharma, Inc.dex1044.htm
EX-10.40 - LICENSE AGREEMENT - SCOLR Pharma, Inc.dex1040.htm
EX-10.43 - FORM OF UNIT PURCHASE AGREEMENT - SCOLR Pharma, Inc.dex1043.htm
EX-10.41 - AMENDMENT NUMBER THREE TO MANUFACTURE LICENSE AND DISTRIBUTION AGREEMENT - SCOLR Pharma, Inc.dex1041.htm
EX-10.42 - TERM SHEET - SCOLR Pharma, Inc.dex1042.htm

Exhibit 23.1

Consent of Grant Thornton LLP, Independent Registered Public Accounting Firm

We have issued our report dated March 24, 2010, with respect to the financial statements included in the Annual Report of SCOLR Pharma, Inc. on Form 10-K for the year ended December 31, 2009. We hereby consent to the incorporation by reference of said report in the Registration Statements of SCOLR Pharma, Inc. on Form S-3 (File Nos. 333-155369, 333-129275, 333-123316 and 333-113949), on Form S-2 (File No. 333-107906) and on Form S-8 (File No. 666-161722, File No. 333-116922, File No. 333-40290, File No. 333-79343).

 

/s/ GRANT THORNTON LLP

 

Seattle, Washington

March 24, 2010